نتائج البحث - "de la Rubia, Javier"

1

دورية أكاديمية

Further psychometric validation of the GAH scale: Responsiveness and effect size.

المصدر: Journal of Geriatric Oncology; May2017, Vol. 8 Issue 3, p211-215, 5p

2

دورية أكاديمية

Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study.

المصدر: Journal of Geriatric Oncology; Jan2023, Vol. 14 Issue 1, pN.PAG-N.PAG, 1p

3

دورية أكاديمية

P-178: Impact of t(11;14) according to induction regimen in newly diagnosed transplant-eligible multiple myeloma patients: long term follow-up of GEM05MENOS65 and GEM2012 PETHEMA/GEM studies.

المصدر: Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 2, Vol. 21, pS134-S135, 2p

4

دورية أكاديمية

P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results.

المصدر: Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 2, Vol. 21, pS109-S110, 2p

5

دورية أكاديمية

P-115: Renal response to rescue treatments in Relapsed Refractory Multiple Myeloma (RRMM) patients with renal impairment: final data of a large, observational, prospective study (MIR50).

المؤلفون: Garcia-Guiñón, Antonio, Morales, Enrique, Sureda, A., González-García, Esther, Durán, María Soledad, Escalante, Fernando, Gironella, M, González-López, Tomás José, Duro, Rafael, Encinas, Manuel Pérez, Ribas, Paz, Cabezudo, Elena, García, Rafael Lluch, Español, Ignacio, Cabanas, Valentín, García-Muñoz, Ricardo, Márquez, José Antonio, Navarro, Mireya, de la Rubia, Javier

المصدر: Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 2, Vol. 21, pS97-S98, 2p

6

دورية أكاديمية

Imipenem/Cilastatin with or without Glycopeptide as Initial Antibiotic Therapy for Recipients of Autologous Stem Cell Transplantation: Results of a Spanish Multicenter Study

المؤلفون: de la Rubia, Javier¹, Montesinos, Pau¹, Martino, Rodrigo², Jarque, Isidro¹, Rovira, Montserrat³, Vázquez, Lourdes⁴, López, Javier⁵, Batlle, Montserrat⁶, de la Cámara, Rafael⁷, Juliá, Antoni⁸, Lahuerta, Juan J.⁹, Debén, Guillermo¹⁰, Díaz, Joaquin¹¹, García, Raimundo¹², Sanz, Miguel A.¹ msanz@uv.es

المصدر: Biology of Blood & Marrow Transplantation. Apr2009, Vol. 15 Issue 4, p512-516. 5p.

مصطلحات موضوعية: *GLYCOPEPTIDES, *ANTIBIOTICS, *STEM cell transplantation, *THERAPEUTICS

النص الكامل

7

دورية أكاديمية

P-165: Chronological age as a prognostic factor in transplant-ineligible patients with newly diagnosed Multiple Myeloma.

المؤلفون: Ruiz, Raquel García, Martínez, Elena Meseguer, Castillo, María Jiménez, Verdet, María Consejo Ortí, Aracil, Eva Francés, Herraiz, Mario Arnao, Ortega, Omara Samantha Cortés, Alcaina, Pilar Solves, Andújar, María José Cejalvo, de la Piedra, Rafael Andreu, Feria, Ana García, García, María Paz Ribas, de la Rubia, Javier

المصدر: Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 2, Vol. 21, pS126-S126, 1p

8

دورية أكاديمية

FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies

المؤلفون: de la Rubia, Javier¹, Regadera, Ana I.¹, Martın, Guillermo¹, Cervera, José¹, Sanz, Guillermo F.¹, Martınez, Jesús A.¹, Jarque, Isidro¹, Garcıa, Inmaculada¹, Andreu, Rafael¹, Moscardó, Federico¹, Jiménez, Carmen¹, Mollá, Susana¹, Benlloch, Luis¹, Sanz, Miguel A. msanz@uv.es

المصدر: Leukemia Research. Aug2002, Vol. 26 Issue 8, p725. 6p.

مصطلحات موضوعية: *MYELOID leukemia, *FLUDARABINE

9

دورية أكاديمية

Therapeutic plasma exchange: Review of current indications.

المؤلفون: Fernández-Zarzoso, Miguel¹ (AUTHOR), Gómez-Seguí, Inés² (AUTHOR), de la Rubia, Javier^1,3 (AUTHOR) delarubia_jav@gva.es

المصدر: Transfusion & Apheresis Science. Jun2019, Vol. 58 Issue 3, p247-253. 7p.

مصطلحات موضوعية: *CLINICAL indications, *BLOOD products, *CELL anatomy, *EXCHANGE, *THERAPEUTICS

10

دورية أكاديمية

Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group.

المؤلفون: Terpos, Evangelos¹ (AUTHOR) eterpos@med.uoa.gr, Zamagni, Elena² (AUTHOR), Lentzsch, Suzanne³ (AUTHOR), Drake, Matthew T⁴ (AUTHOR), García-Sanz, Ramón⁵ (AUTHOR), Abildgaard, Niels⁶ (AUTHOR), Ntanasis-Stathopoulos, Ioannis¹ (AUTHOR), Schjesvold, Fredrik⁷ (AUTHOR), de la Rubia, Javier⁸ (AUTHOR), Kyriakou, Charalampia⁹ (AUTHOR), Hillengass, Jens¹⁰ (AUTHOR), Zweegman, Sonja¹¹ (AUTHOR), Cavo, Michele² (AUTHOR), Moreau, Philippe¹² (AUTHOR), San-Miguel, Jesus¹³ (AUTHOR), Dimopoulos, Meletios A¹ (AUTHOR), Munshi, Nikhil¹⁴ (AUTHOR), Durie, Brian G M¹⁵ (AUTHOR), Raje, Noopur¹⁶ (AUTHOR), Bone Working Group of the International Myeloma Working Group (CORPORATE AUTHOR)

المصدر: Lancet Oncology. Mar2021, Vol. 22 Issue 3, pe119-e130. 12p.

مصطلحات موضوعية: *BONE diseases, *SPINAL cord compression, *VERTEBRAE injuries, *SPINE, *SPONTANEOUS fractures, *ZOLEDRONIC acid

تنقيح النتائج